We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Magnetic Needle Performs Less Invasive, More Precise Surgery and Diagnostic Tests

By LabMedica International staff writers
Posted on 25 Apr 2022

A tiny, untethered needle can enter the body through an incision no larger than a pin prick to perform biopsies, suture wounds, and even deliver cancer-fighting chemotherapy directly to tumors. More...

Controlled by externally applied magnetics forces—no attached, guiding wires, or human or robotic hands—these miniscule tools promise a future of more precise, safer, and far less invasive surgery, experts say. However, as devices get smaller, so does their response to the magnetic forces that cause them to move and steer their course. Now, researchers have a solution: a surgical needle equipped with small magnets inside that, when stimulated by the externally applied forces, slip from one end of the needle to another, tapping against a rigid plate and supplying ample force to penetrate tissue.

In a study, a team of researchers at the Johns Hopkins Whiting School of Engineering (Baltimore, MD, USA) have demonstrated for the first time that untethered magnetic needles can be forceful enough to accomplish surgery. The researchers call their device the "Pulse Actuated Collisions for Tissue-penetrating Needle," or MPACT-Needle. For their experiments, the team connected a slender thread of suturing material to the needle, using a joystick connected to a computer to deliver commands that enabled the MPACT-Needle to perform surgical suturing on a sample rabbit cornea.

The team's next step is to develop better, more accurate motion-control algorithms equipped with imaging modalities to precisely control the movement of the device, making surgeries and procedures safer. The researchers believe that if the technology becomes successful, their new magnetic needles would make it possible to access hard-to-reach, delicate areas of the body, such as the bile duct, to deliver drugs directly to tumors, extract biopsy samples, or suture a wound rapidly and effectively to stem internal bleeding.

"These extremely small tools have the potential to revolutionize medicine, but as anyone who has played with magnets knows, size is important," said Axel Krieger, an assistant professor of mechanical engineering at Johns Hopkins Whiting School of Engineering. "The smaller the surgical tool, the less invasive the surgery, but also the weaker the device's response to magnetic force. One of the biggest challenges facing us is how to make sure that these mini-tools can be moved with enough force to penetrate tissue and do the job they are there to do."

"We proved that these tiny magnetic needles can have strong enough forces to perform delicate surgery with limited invasiveness," said study leader Onder Erin, a postdoctoral fellow in mechanical engineering at Johns Hopkins. "I can envision a time when our device will also be used to perform biopsies, and even deliver therapeutics and chemotherapy directly to tumors."

Related Links:
Johns Hopkins Whiting School of Engineering 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Elevated creatinine levels do not necessarily indicate impaired kidney function: pre-treatment cystatin C measurement is key to assessment (Image Credit: Data panels adapted from Watanabe H, et al. Clin Pharmacol Ther (2026). All icons were obtained from bioicons.com and modified.)

Cystatin C Testing Helps Distinguish Abemaciclib Effect from Kidney Injury

Kidney function monitoring in breast cancer care often relies on serum creatinine, a routine blood marker used to estimate renal function. However, creatinine increases in patients receiving abemaciclib... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: The test uses serum or plasma from patients with suspected acute infection and symptoms lasting fewer than seven days and generates a score indicating the likelihood of bacterial infection. (Image Credit: Shutterstock)

Rapid Host-Response Assay Gains FDA Clearance to Help Distinguish Bacterial and Viral Infections

Bacterial and viral infections often cause similar symptoms, making early differentiation difficult in emergency and urgent care settings. Clinicians may need to begin treatment before traditional diagnostic... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.